Full-Time

Director – Global Regulatory Labeling

Respiratory Franchise

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

70% in-office structure.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • BA/BS degree in a scientific discipline required, Masters or PhD preferred.
  • 10+ years of experience in the pharmaceutical industry
  • 7+ years of experience in Regulatory labeling
  • Strong knowledge of artwork development, review and approval required.
  • Strong knowledge of current global regulations, including specifically: e.g. vaccine development regulations and registrations pathways.
  • Strong experience with CTD format and content regulatory filings
  • Exceptional written and oral communication
  • Experience dealing with broad range of stakeholders at all levels internal and external to the company
  • Delivery of labeling for at least one major application (NDA/BLA/MAA, etc.)
  • Experience facilitating meetings and driving consensus and results.
  • Excellent leadership, communication (verbal and written) and collaboration skills.
  • Proven ability in medical/technical writing.
  • Labeling experience (CCDS, US, EU, other major markets) in infectious diseases or vaccines or other relevant industry experience related to developing regulatory documentation is desirable.
  • Innate sense of urgency in regards to FDA/EMA/MHRA/other HA communications and response timelines to provide coverage for product approvals and labeling negotiations.
  • Integrity: overriding commitment to integrity and high standards in self and others.
  • Achievement or result orientation: a concern for working well or for surpassing a standard of excellence.
  • Strategic orientation: ability to link visions and daily work
  • Communication: ability and intend to effectively explain, describe or convey information to a variety of audiences. Specifically, interacts effectively as member of the regulatory sub-team, communicates effectively on these strategies to the Global Labeling Committee and collaborates with business partners, including affiliates and third parties.
  • Develops others: involved in a genuine intent to foster development of others; mentoring
  • Flexibility/adaptability: ability to adapt to, and work effectively within a variety of situations and with various individuals or groups.
  • Relationship building, teamwork and cooperation: builds or maintains friendly relationship with people and demonstrates desire to work.
  • Problem solving and analytical thinking: understand a situation by breaking it apart into small pieces or tracing the implications of a situation in a step-by-step way. Systematically organizing the parts of a problem.
Responsibilities
  • Develop and maintain current knowledge of labeling regulations and industry standards for labeling and communicate requirements to stakeholders as needed.
  • Direct the labeling control process for tracking, implementation, and regulatory submission of new labeling for US/major markets for Moderna’s respiratory franchise products.
  • Develops labeling content, format and accountability for regulatory submissions (BLAs) and related supplements and amendments. Ensure that new labeling text meets regulatory labeling requirements.
  • Develops content for artwork related to BLAs and related supplements and amendments. Works with cross-functional team and provides input on new trade names, established names, graphics and logos.
  • Interface with Project Teams to ensure consistency of labeling processes and local compliance with CCDS.
  • Effectively communicate the regulatory labeling strategy, risks, mitigations and overall plans to the Global Regulatory Science Management Team, Project Development Team and senior management, as relevant.
  • Partner with the Global Regulatory Lead to develop Target Label Profiles to support all phases of clinical development.
  • Provide input to the end-to-end labeling process.
  • Liaise within pharmaceutical/biotech industry to maintain knowledge of evolving/emerging industry standards and trends; and influences the industry environment regarding labeling.
  • This position may need to help with coverage on other products during peak periods or during absences of other team members.
  • May be responsible for line management and development of direct reports in the future.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?